KENNETH R HESS to Proto-Oncogene Proteins B-raf
This is a "connection" page, showing publications KENNETH R HESS has written about Proto-Oncogene Proteins B-raf.
Connection Strength
0.219
-
Beneficial Effect of Adjuvant Dabrafenib Plus Trametinib on Recurrence-Free Survival in Patients With Resected BRAFV600-Mutant Stage III Melanoma Seems to be Short-Lived. J Clin Oncol. 2019 05 20; 37(15):1354-1355.
Score: 0.103
-
Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma Tumors. J Natl Cancer Inst. 2017 10 01; 109(10).
Score: 0.093
-
Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid. 2018 01; 28(1):79-87.
Score: 0.024